Mercy BioAnalytics Receives FDA Approval to Initiate Prospective Pivotal Study of Evident™Ovarian Cancer Screening Test
September 28, 2026
IDE approval enables initiation of the pivotal Safety in Ovarian Cancer for Average-Risk Women – Analysis (“SOARA”) Clinical Validation Study following Institutional Review Board approval
